The Characteristics, Mechanisms and Therapeutics: Exploring the Role of Gut Microbiota in Obesity

References

• Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217. doi:10.1016/j.metabol.2022.155217
   PubMedGoogle Scholar
• Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: a Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984–e1010. doi:10.1161/CIR.0000000000000973
   PubMed Web of Science ®Google Scholar
• Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2018;15(4):230–240. doi:10.1038/nrcardio.2017.154
   PubMed Web of Science ®Google Scholar
• Makri E, Goulas A, Polyzos SA. Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease. Arch Med Res. 2021;52(1):25–37. doi:10.1016/j.arcmed.2020.11.010
   PubMed Web of Science ®Google Scholar
• Piche ME, Tchernof A, Despres JP. Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circ Res. 2020;126(11):1477–1500. doi:10.1161/CIRCRESAHA.120.316101
   PubMed Web of Science ®Google Scholar
• Lemieux I, Després JP. Metabolic Syndrome: past, Present and Future. Nutrients. 2020;12(11):3501. doi:10.3390/nu12113501
   PubMed Web of Science ®Google Scholar
• Wolfe BM, Kvach E, Eckel RH. Treatment of Obesity: weight Loss and Bariatric Surgery. Circ Res. 2016;118(11):1844–1855. doi:10.1161/CIRCRESAHA.116.307591
   PubMed Web of Science ®Google Scholar
• Khera R, Murad MH, Chandar AK, et al. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: a Systematic Review and Meta-analysis. JAMA. 2016;315(22):2424–2434. doi:10.1001/jama.2016.7602
   PubMed Web of Science ®Google Scholar
• Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science. 2012;336(6086):1255–1262. doi:10.1126/science.1224203
   PubMed Web of Science ®Google Scholar
• Berg G, Rybakova D, Fischer D, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020;8(1):103. doi:10.1186/s40168-020-00875-0
   PubMed Web of Science ®Google Scholar
• Abdul Rahim MBH, Chilloux J, Martinez-Gili L, et al. Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles. Acta Diabetol. 2019;56(5):493–500. doi:10.1007/s00592-019-01312-x
   PubMed Web of Science ®Google Scholar
• Leibovitzh H, Lee SH, Xue M, et al. Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease. Gastroenterology. 2022;163(5):1364–1376.e1310. doi:10.1053/j.gastro.2022.07.004
   PubMed Web of Science ®Google Scholar
• Li W, Deng Y, Chu Q, Zhang P. Gut microbiome and cancer immunotherapy. Cancer Lett. 2019;447:41–47. doi:10.1016/j.canlet.2019.01.015
   PubMed Web of Science ®Google Scholar
• Gacesa R, Kurilshikov A, Vich Vila A, et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature. 2022;604(7907):732–739.
   PubMed Web of Science ®Google Scholar
• Geng J, Ni Q, Sun W, Li L, Feng X. The links between gut microbiota and obesity and obesity related diseases. Biomed Pharmacother. 2022;147:112678. doi:10.1016/j.biopha.2022.112678
   PubMed Web of Science ®Google Scholar
• Silva JSC, Seguro CS, Naves MMV. Gut microbiota and physical exercise in obesity and diabetes - A systematic review. Nutr Metab Cardiovasc Dis. 2022;32(4):863–877. doi:10.1016/j.numecd.2022.01.023
   PubMed Web of Science ®Google Scholar
• Ribeiro FM, Silva MA, Lyssa V, et al. The molecular signaling of exercise and obesity in the microbiota-gut-brain axis. Front Endocrinol (Lausanne). 2022;13:927170. doi:10.3389/fendo.2022.927170
   PubMed Web of Science ®Google Scholar
• Rabot S, Membrez M, Bruneau A, et al. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB j. 2010;24(12):4948–4959. doi:10.1096/fj.10-164921
   PubMed Web of Science ®Google Scholar
• Fei N, Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. Isme j. 2013;7(4):880–884. doi:10.1038/ismej.2012.153
   PubMed Web of Science ®Google Scholar
• John GK, Mullin GE. The Gut Microbiome and Obesity. Curr Oncol Rep. 2016;18(7):45. doi:10.1007/s11912-016-0528-7
   PubMed Web of Science ®Google Scholar
• Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913–916.e917. doi:10.1053/j.gastro.2012.06.031
   PubMed Web of Science ®Google Scholar
• Pinart M, Dotsch A, Schlicht K, et al. Gut Microbiome Composition in Obese and Non-Obese Persons: a Systematic Review and Meta-Analysis. Nutrients. 2021;14(1):12. doi:10.3390/nu14010012
   PubMed Web of Science ®Google Scholar
• Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070–11075. doi:10.1073/pnas.0504978102
   PubMed Web of Science ®Google Scholar
• Andoh A, Nishida A, Takahashi K, et al. Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population. J Clin Biochem Nutr. 2016;59(1):65–70. doi:10.3164/jcbn.15-152
   PubMed Web of Science ®Google Scholar
• Koliada A, Syzenko G, Moseiko V, et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017;17(1):120. doi:10.1186/s12866-017-1027-1
   PubMed Web of Science ®Google Scholar
• Gao X, Zhang M, Xue J, et al. Body Mass Index Differences in the Gut Microbiota Are Gender Specific. Front Microbiol. 2018;9:1250. doi:10.3389/fmicb.2018.01250
   PubMed Web of Science ®Google Scholar
• Murga-Garrido SM, Orbe-Orihuela YC, Díaz-Benítez CE, et al. Alterations of the Gut Microbiome Associated to Methane Metabolism in Mexican Children with Obesity. Children. 2022;9(2). doi:10.3390/children9020148
   PubMedGoogle Scholar
• Yun Y, Kim HN, Kim SE, et al. Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort. BMC Microbiol. 2017;17(1):151. doi:10.1186/s12866-017-1052-0
   PubMed Web of Science ®Google Scholar
• Peters BA, Shapiro JA, Church TR, et al. A taxonomic signature of obesity in a large study of American adults. Sci Rep. 2018;8(1):9749. doi:10.1038/s41598-018-28126-1
   PubMedGoogle Scholar
• Chávez-Carbajal A, Nirmalkar K, Pérez-Lizaur A, et al. Gut Microbiota and Predicted Metabolic Pathways in a Sample of Mexican Women Affected by Obesity and Obesity Plus Metabolic Syndrome. Int J Mol Sci. 2019;20(2):438. doi:10.3390/ijms20020438
   PubMed Web of Science ®Google Scholar
• Oduaran OH, Tamburini FB, Sahibdeen V, et al. Gut microbiome profiling of a rural and urban South African cohort reveals biomarkers of a population in lifestyle transition. BMC Microbiol. 2020;20(1):330. doi:10.1186/s12866-020-02017-w
   PubMed Web of Science ®Google Scholar
• Loftfield E, Herzig KH, Caporaso JG, et al. Association of Body Mass Index with Fecal Microbial Diversity and Metabolites in the Northern Finland Birth Cohort. Cancer Epidemiol Biomarkers Prev. 2020;29(11):2289–2299. doi:10.1158/1055-9965.EPI-20-0824
   PubMed Web of Science ®Google Scholar
• Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK. Effects of gut microbes on nutrient absorption and energy regulation. Nutr Clin Pract. 2012;27(2):201–214. doi:10.1177/0884533611436116
   PubMed Web of Science ®Google Scholar
• Mithieux G. New data and concepts on glutamine and glucose metabolism in the gut. Curr Opin Clin Nutr Metab Care. 2001;4(4):267–271. doi:10.1097/00075197-200107000-00004
   PubMed Web of Science ®Google Scholar
• Brahe LK, Astrup A, Larsen LH. Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? Obes Rev. 2013;14(12):950–959. doi:10.1111/obr.12068
   PubMed Web of Science ®Google Scholar
• Mandard S, Zandbergen F, van Straten E, et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem. 2006;281(2):934–944. doi:10.1074/jbc.M506519200
   PubMed Web of Science ®Google Scholar
• Lin HV, Frassetto A, Kowalik Jr EJ Jr, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One. 2012;7(4):e35240. doi:10.1371/journal.pone.0035240
   PubMed Web of Science ®Google Scholar
• Blaak EE, Canfora EE, Theis S, et al. Short chain fatty acids in human gut and metabolic health. Benef Microbes. 2020;11(5):411–455. doi:10.3920/BM2020.0057
   PubMed Web of Science ®Google Scholar
• Schwiertz A, Taras D, Schafer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity. 2010;18(1):190–195. doi:10.1038/oby.2009.167
   PubMed Web of Science ®Google Scholar
• de la Cuesta-Zuluaga J, Mueller NT, Alvarez-Quintero R, et al. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors. Nutrients. 2018;11(1):51. doi:10.3390/nu11010051
   PubMed Web of Science ®Google Scholar
• Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–868. doi:10.1038/nm.4358
   PubMed Web of Science ®Google Scholar
• Virtue AT, McCright SJ, Wright JM, et al. The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Sci Transl Med. 2019;11(496). doi:10.1126/scitranslmed.aav1892
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241–259. doi:10.1194/jlr.R500013-JLR200
   PubMed Web of Science ®Google Scholar
• Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M. Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis. 2010;28(1):220–224. doi:10.1159/000282091
   PubMed Web of Science ®Google Scholar
• Bhatnagar S, Damron HA, Hillgartner FB. Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J Biol Chem. 2009;284(15):10023–10033. doi:10.1074/jbc.M808818200
   PubMed Web of Science ®Google Scholar
• Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31–55. doi:10.1016/j.immuni.2021.12.013
   PubMed Web of Science ®Google Scholar
• Saad MJ, Santos A, Prada PO. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. Physiology. 2016;31(4):283–293. doi:10.1152/physiol.00041.2015
   PubMed Web of Science ®Google Scholar
• Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110(22):9066–9071. doi:10.1073/pnas.1219451110
   PubMed Web of Science ®Google Scholar
• Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF. The microbiota-gut-brain axis in obesity. Lancet Gastroenterol Hepatol. 2017;2(10):747–756. doi:10.1016/S2468-1253(17)30147-4
   PubMed Web of Science ®Google Scholar
• Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY. Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88. J Immunol. 2015;195(10):4999–5010. doi:10.4049/jimmunol.1402598
   PubMed Web of Science ®Google Scholar
• Tanti JF, Ceppo F, Jager J, Berthou F. Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne). 2012;3:181. doi:10.3389/fendo.2012.00181
   PubMedGoogle Scholar
• Neal MD, Leaphart C, Levy R, et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol. 2006;176(5):3070–3079. doi:10.4049/jimmunol.176.5.3070
   PubMed Web of Science ®Google Scholar
• Behzadi P, García-Perdomo HA, Karpiński TM. Toll-Like Receptors: general Molecular and Structural Biology. J Immunol Res. 2021;2021:9914854. doi:10.1155/2021/9914854
   PubMed Web of Science ®Google Scholar
• Chng MH, Alonso MN, Barnes SE, Nguyen KD, Engleman EG. Adaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance. Mediators Inflamm. 2015;2015:593075. doi:10.1155/2015/593075
   PubMed Web of Science ®Google Scholar
• Fuchs A, Samovski D, Smith GI, et al. Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2021;161(3):968–981.e912. doi:10.1053/j.gastro.2021.05.008
   PubMed Web of Science ®Google Scholar
• Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 2014;510(7503):84–91.
   PubMed Web of Science ®Google Scholar
• Gasmi A, Noor S, Menzel A, Doşa A, Pivina L, Bjørklund G. Obesity and Insulin Resistance: associations with Chronic Inflammation, Genetic and Epigenetic Factors. Curr Med Chem. 2021;28(4):800–826. doi:10.2174/0929867327666200824112056
   PubMed Web of Science ®Google Scholar
• Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375–C391. doi:10.1152/ajpcell.00379.2020
   PubMed Web of Science ®Google Scholar
• Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8(1):42. doi:10.1186/s13073-016-0303-2
   PubMedGoogle Scholar
• Arkan MC, Hevener AL, Greten FR, et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med. 2005;11(2):191–198. doi:10.1038/nm1185
   PubMed Web of Science ®Google Scholar
• Lafferty RA, Flatt PR, Irwin N. Emerging therapeutic potential for peptide YY for obesity-diabetes. Peptides. 2018;100:269–274. doi:10.1016/j.peptides.2017.11.005
   PubMed Web of Science ®Google Scholar
• Khandekar N, Berning BA, Sainsbury A, Lin S. The role of pancreatic polypeptide in the regulation of energy homeostasis. Mol Cell Endocrinol. 2015;418(Pt 1):33–41. doi:10.1016/j.mce.2015.06.028
   PubMedGoogle Scholar
• Salehi M, Purnell JQ. The Role of Glucagon-Like Peptide-1 in Energy Homeostasis. Metab Syndr Relat Disord. 2019;17(4):183–191. doi:10.1089/met.2018.0088
   PubMed Web of Science ®Google Scholar
• Cheng Z, Zhang L, Yang L, Chu H. The critical role of gut microbiota in obesity. Front Endocrinol (Lausanne). 2022;13:1025706. doi:10.3389/fendo.2022.1025706
   PubMed Web of Science ®Google Scholar
• Karra E, Chandarana K, Batterham RL. The role of peptide YY in appetite regulation and obesity. J Physiol. 2009;587(1):19–25. doi:10.1113/jphysiol.2008.164269
   PubMed Web of Science ®Google Scholar
• Federico A, Dallio M, Tolone S, et al. Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: effect of Bariatric Surgery. Vivo. 2016;30(3):321–330.
   PubMed Web of Science ®Google Scholar
• Schéle E, Grahnemo L, Anesten F, Hallén A, Bäckhed F, Jansson JO. The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system. Endocrinology. 2013;154(10):3643–3651. doi:10.1210/en.2012-2151
   PubMed Web of Science ®Google Scholar
• Chimerel C, Emery E, Summers DK, Keyser U, Gribble FM, Reimann F. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 2014;9(4):1202–1208. doi:10.1016/j.celrep.2014.10.032
   PubMed Web of Science ®Google Scholar
• Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364–371. doi:10.2337/db11-1019
   PubMed Web of Science ®Google Scholar
• Modasia A, Parker A, Jones E, et al. Regulation of Enteroendocrine Cell Networks by the Major Human Gut Symbiont Bacteroides thetaiotaomicron. Front Microbiol. 2020;11:575595. doi:10.3389/fmicb.2020.575595
   PubMed Web of Science ®Google Scholar
• Larraufie P, Martin-Gallausiaux C, Lapaque N, et al. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Sci Rep. 2018;8(1):74. doi:10.1038/s41598-017-18259-0
   PubMedGoogle Scholar
• Wong DH, Beiko RG. Transfer of energy pathway genes in microbial enhanced biological phosphorus removal communities. BMC Genomics. 2015;16(1):526. doi:10.1186/s12864-015-1752-5
   PubMedGoogle Scholar
• Silberbauer CJ, Surina-Baumgartner DM, Arnold M, Langhans W. Prandial lactate infusion inhibits spontaneous feeding in rats. Am J Physiol Regul Integr Comp Physiol. 2000;278(3):R646–R653. doi:10.1152/ajpregu.2000.278.3.R646
   PubMed Web of Science ®Google Scholar
• Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG, Stanton C. Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol. 2014;817:221–239.
   PubMed Web of Science ®Google Scholar
• Delgado TC. Glutamate and GABA in Appetite Regulation. Front Endocrinol (Lausanne). 2013;4:103. doi:10.3389/fendo.2013.00103
   PubMedGoogle Scholar
• Strandwitz P, Kim KH, Terekhova D, et al. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol. 2019;4(3):396–403. doi:10.1038/s41564-018-0307-3
   PubMed Web of Science ®Google Scholar
• Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693(Pt B):128–133. doi:10.1016/j.brainres.2018.03.015
   PubMedGoogle Scholar
• Patterson E, Ryan PM, Wiley N, et al. Gamma-aminobutyric acid-producing lactobacilli positively affect metabolism and depressive-like behaviour in a mouse model of metabolic syndrome. Sci Rep. 2019;9(1):16323. doi:10.1038/s41598-019-51781-x
   PubMedGoogle Scholar
• Kootte RS, Levin E, Salojärvi J, et al. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. Cell Metab. 2017;26(4):611–619.e616. doi:10.1016/j.cmet.2017.09.008
   PubMed Web of Science ®Google Scholar
• Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PP. Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis. Nutrients. 2016;8(1). doi:10.3390/nu8010056
   PubMed Web of Science ®Google Scholar
• Heisler LK, Jobst EE, Sutton GM, et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron. 2006;51(2):239–249. doi:10.1016/j.neuron.2006.06.004
   PubMed Web of Science ®Google Scholar
• van Galen KA, Ter Horst KW, Booij J, la Fleur SE, Serlie MJ. The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies. Metabolism. 2018;85:325–339. doi:10.1016/j.metabol.2017.09.007
   PubMed Web of Science ®Google Scholar
• Hartstra AV, Schüppel V, Imangaliyev S, et al. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome. Mol Metab. 2020;42:101076. doi:10.1016/j.molmet.2020.101076
   PubMed Web of Science ®Google Scholar
• de Araujo IE, Schatzker M, Small DM. Rethinking Food Reward. Annu Rev Psychol. 2020;71(1):139–164. doi:10.1146/annurev-psych-122216-011643
   PubMedGoogle Scholar
• Riediger T. The receptive function of hypothalamic and brainstem centres to hormonal and nutrient signals affecting energy balance. Proc Nutr Soc. 2012;71(4):463–477. doi:10.1017/S0029665112000778
   PubMed Web of Science ®Google Scholar
• Luo SX, Huang EJ. Dopaminergic Neurons and Brain Reward Pathways: from Neurogenesis to Circuit Assembly. Am J Pathol. 2016;186(3):478–488. doi:10.1016/j.ajpath.2015.09.023
   PubMed Web of Science ®Google Scholar
• Arias-Carrión O, Stamelou M, Murillo-Rodríguez E, Menéndez-González M, Pöppel E. Dopaminergic reward system: a short integrative review. Int Arch Med. 2010;3:24. doi:10.1186/1755-7682-3-24
   PubMedGoogle Scholar
• Ueno H, Nakazato M. Mechanistic relationship between the vagal afferent pathway, central nervous system and peripheral organs in appetite regulation. J Diabetes Investig. 2016;7(6):812–818. doi:10.1111/jdi.12492
   PubMed Web of Science ®Google Scholar
• van Son J, Koekkoek LL, La Fleur SE, Serlie MJ, Nieuwdorp M. The Role of the Gut Microbiota in the Gut-Brain Axis in Obesity: mechanisms and Future Implications. Int J Mol Sci. 2021;22(6):2993. doi:10.3390/ijms22062993
   PubMed Web of Science ®Google Scholar
• Sen T, Cawthon CR, Ihde BT, et al. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity. Physiol Behav. 2017;173:305–317. doi:10.1016/j.physbeh.2017.02.027
   PubMed Web of Science ®Google Scholar
• de La Serre CB, de Lartigue G, Raybould HE. Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiol Behav. 2015;139:188–194. doi:10.1016/j.physbeh.2014.10.032
   PubMed Web of Science ®Google Scholar
• Jadhav KS, Peterson VL, Halfon O, et al. Gut microbiome correlates with altered striatal dopamine receptor expression in a model of compulsive alcohol seeking. Neuropharmacology. 2018;141:249–259. doi:10.1016/j.neuropharm.2018.08.026
   PubMed Web of Science ®Google Scholar
• Nettleton JE, Klancic T, Schick A, et al. Low-Dose Stevia (Rebaudioside A) Consumption Perturbs Gut Microbiota and the Mesolimbic Dopamine Reward System. Nutrients. 2019;11(6):1248. doi:10.3390/nu11061248
   PubMed Web of Science ®Google Scholar
• Hamamah S, Aghazarian A, Nazaryan A, Hajnal A, Covasa M. Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling. Biomedicines. 2022;10(2):436. doi:10.3390/biomedicines10020436
   PubMed Web of Science ®Google Scholar
• de Wouters d’Oplinter A, Huwart SJP, Cani PD, Everard A. Gut microbes and food reward: from the gut to the brain. Front Neurosci. 2022;16:947240. doi:10.3389/fnins.2022.947240
   PubMed Web of Science ®Google Scholar
• Nettleton JE, Cho NA, Klancic T, et al. Maternal low-dose aspartame and stevia consumption with an obesogenic diet alters metabolism, gut microbiota and mesolimbic reward system in rat dams and their offspring. Gut. 2020;69(10):1807–1817. doi:10.1136/gutjnl-2018-317505
   PubMed Web of Science ®Google Scholar
• Schaack B, Hindré T, Quansah N, Hannani D, Mercier C, Laurin D. Microbiota-Derived Extracellular Vesicles Detected in Human Blood from Healthy Donors. Int J Mol Sci. 2022;23(22):13787. doi:10.3390/ijms232213787
   PubMed Web of Science ®Google Scholar
• Chelakkot C, Choi Y, Kim DK, et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. 2018;50(2):e450. doi:10.1038/emm.2017.282
   PubMed Web of Science ®Google Scholar
• Hiippala K, Barreto G, Burrello C, et al. Novel Odoribacter splanchnicus Strain and Its Outer Membrane Vesicles Exert Immunoregulatory Effects in vitro. Front Microbiol. 2020;11:575455. doi:10.3389/fmicb.2020.575455
   PubMed Web of Science ®Google Scholar
• Cañas MA, Fábrega MJ, Giménez R, Badia J, Baldomà L. Outer Membrane Vesicles From Probiotic and Commensal Escherichia coli Activate NOD1-Mediated Immune Responses in Intestinal Epithelial Cells. Front Microbiol. 2018;9:498. doi:10.3389/fmicb.2018.00498
   PubMed Web of Science ®Google Scholar
• Choi Y, Kwon Y, Kim DK, et al. Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle. Sci Rep. 2015;5:15878. doi:10.1038/srep15878
   PubMed Web of Science ®Google Scholar
• Gao H, Luo Z, Ji Y, et al. Accumulation of microbial DNAs promotes to islet inflammation and beta cell abnormalities in obesity in mice. Nat Commun. 2022;13(1):565. doi:10.1038/s41467-022-28239-2
   PubMed Web of Science ®Google Scholar
• Antushevich H. Fecal microbiota transplantation in disease therapy. Clin Chim Acta. 2020;503:90–98. doi:10.1016/j.cca.2019.12.010
   PubMed Web of Science ®Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–415. doi:10.1056/NEJMoa1205037
   PubMed Web of Science ®Google Scholar
• Wang JW, Kuo CH, Kuo FC, et al. Fecal microbiota transplantation: review and update. J Formos Med Assoc. 2019;118(Suppl 1):S23–s31. doi:10.1016/j.jfma.2018.08.011
   PubMed Web of Science ®Google Scholar
• de Groot P, Scheithauer T, Bakker GJ, et al. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time. Gut. 2020;69(3):502–512. doi:10.1136/gutjnl-2019-318320
   PubMed Web of Science ®Google Scholar
• Mocanu V, Zhang Z, Deehan EC, et al. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled Phase 2 trial. Nat Med. 2021;27(7):1272–1279. doi:10.1038/s41591-021-01399-2
   PubMed Web of Science ®Google Scholar
• DeFilipp Z, Bloom PP, Torres Soto M, et al. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. N Engl J Med. 2019;381(21):2043–2050. doi:10.1056/NEJMoa1910437
   PubMed Web of Science ®Google Scholar
• Baxter M, Colville A. Adverse events in faecal microbiota transplant: a review of the literature. J Hosp Infect. 2016;92(2):117–127. doi:10.1016/j.jhin.2015.10.024
   PubMed Web of Science ®Google Scholar
• Leong KSW, Jayasinghe TN, Wilson BC, et al. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: the Gut Bugs Randomized Controlled Trial. JAMA Netw Open. 2020;3(12):e2030415. doi:10.1001/jamanetworkopen.2020.30415
   PubMed Web of Science ®Google Scholar
• Yu EW, Gao L, Stastka P, et al. Fecal microbiota transplantation for the improvement of metabolism in obesity: the FMT-TRIM double-blind placebo-controlled pilot trial. PLoS Med. 2020;17(3):e1003051. doi:10.1371/journal.pmed.1003051
   PubMed Web of Science ®Google Scholar
• Beyaz Coşkun A, Sağdiçoğlu Celep AG. Therapeutic modulation methods of gut microbiota and gut-liver axis. Crit Rev Food Sci Nutr. 2022;62(23):6505–6515. doi:10.1080/10408398.2021.1902263
   PubMed Web of Science ®Google Scholar
• Marttinen M, Ala-Jaakkola R, Laitila A, Lehtinen MJ. Gut Microbiota, Probiotics and Physical Performance in Athletes and Physically Active Individuals. Nutrients. 2020;12(10):2936. doi:10.3390/nu12102936
   PubMed Web of Science ®Google Scholar
• Cerdó T, García-Santos JA, Campoy C. The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity. Nutrients. 2019;11(3):635. doi:10.3390/nu11030635
   PubMed Web of Science ®Google Scholar
• Abenavoli L, Scarpellini E, Colica C, et al. Gut Microbiota and Obesity: a Role for Probiotics. Nutrients. 2019;11(11):2690. doi:10.3390/nu11112690
   PubMed Web of Science ®Google Scholar
• Dror T, Dickstein Y, Dubourg G, Paul M. Microbiota manipulation for weight change. Microb Pathog. 2017;106:146–161. doi:10.1016/j.micpath.2016.01.002
   PubMed Web of Science ®Google Scholar
• Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism. 2018;79:97–107. doi:10.1016/j.metabol.2017.12.010
   PubMed Web of Science ®Google Scholar
• Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365–2370. doi:10.1073/pnas.0812600106
   PubMed Web of Science ®Google Scholar
• Li JV, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut. 2011;60(9):1214–1223. doi:10.1136/gut.2010.234708
   PubMed Web of Science ®Google Scholar
• Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5(178):178ra141. doi:10.1126/scitranslmed.3005687
   Web of Science ®Google Scholar
• Peluso MA, Guerra de Andrade LH. Physical activity and mental health: the association between exercise and mood. Clinics. 2005;60(1):61–70. doi:10.1590/S1807-59322005000100012
   PubMedGoogle Scholar
• Carbone S, Del Buono MG, Ozemek C, Lavie CJ. Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness. Prog Cardiovasc Dis. 2019;62(4):327–333. doi:10.1016/j.pcad.2019.08.004
   PubMed Web of Science ®Google Scholar
• Mitchell CM, Davy BM, Hulver MW, Neilson AP, Bennett BJ, Davy KP. Does Exercise Alter Gut Microbial Composition? A Systematic Review. Med Sci Sports Exerc. 2019;51(1):160–167. doi:10.1249/MSS.0000000000001760
   PubMed Web of Science ®Google Scholar
• Bressa C, Bailén-Andrino M, Pérez-Santiago J, et al. Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS One. 2017;12(2):e0171352. doi:10.1371/journal.pone.0171352
   PubMed Web of Science ®Google Scholar
• Mahdieh MS, Maryam J, Bita B, et al. A pilot study on the relationship between Lactobacillus, Bifidibactrium counts and inflammatory factors following exercise training. Arch Physiol Biochem. 2023;129(3):778–787. doi:10.1080/13813455.2021.1871763
   PubMed Web of Science ®Google Scholar